Literature DB >> 7549028

Morphology of the mucosal lesion in gluten sensitivity.

M N Marsh1, P T Crowe.   

Abstract

Gluten sensitivity is associated with a spectrum of mucosal lesions, arbitrarily termed pre-infiltrative, infiltrative-hyperplastic, flat-destructive and atrophic-hypoplastic. Histologically and immunohistologically these lesions are all compatible with T-cell-driven events operative at a local mucosal level. They are classifiable either in terms of antibody titres (pre-infiltrative) (see Chapter 10) or by the characteristic disposition of IELs throughout the surface and crypt epithelium. From in-vivo challenges, it has been demonstrated: (i) that all these lesions comprise a dynamically interrelated series of events, culminating in the severe flat-destructive lesion; and (ii) that gluten evokes a dose-responsive infiltration of IELs (CD3+ CD8+ and TCR alpha beta + or gamma delta +) into the epithelium. Apart from that, little is known of the functions of IELs; it is possible they may have little to do with the evolving mucosal pathology of gluten sensitivity. Increasing work seems to support a view, proposed from this laboratory over 10 years ago, that the immune-mediated responses in jejunal tissue in gluten sensitivity arise in the lamina propria, in association with DR+ macrophages and an abundance of CD4(+)-activated lymphocytes. Many other inflammatory consequences flow from these interactions, involving activation of mast cells, eosinophils and neutrophils, elaboration of cytokines and other products of inflammation, and increased hyperpermeability of the microvasculature with upregulation of adhesion molecules. The result is a doubling of lamina propria volumes in the severe flat lesion. Evidence is also given to show that measurable changes in lamina propria inflammation occur with the infiltrative-hyperplastic lesion. Symptomatology is not related to the degree of proximal mucosal pathology, but to the extent of the mucosal lesion. Data, although scanty, suggests that lesional pathology involves only 30-50% of the entire small bowel mucosa. Thus, most patients, irrespective of proximal mucosal damage, have latent (or asymptomatic) gluten sensitivity. Symptom development requires additional environmental triggers, of which infection is a major contributor. It should also be noted that, while these various environmental triggers may precipitate symptomatology, they do not advance the severity of the mucosal lesion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549028     DOI: 10.1016/0950-3528(95)90032-2

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  78 in total

1.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; S D'Alò; R Parroni; D Millimaggi; M G Cifone; G R Corazza
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

Review 3.  Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.

Authors:  Fabio Panetta; Valerio Nobili; Maria Rita Sartorelli; Raffaele Edo Papa; Francesca Ferretti; Arianna Alterio; Antonella Diamanti
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

4.  Prevalence of celiac disease in nutritional anemia at a tertiary care center.

Authors:  Amit Kavimandan; Meenakshi Sharma; Anil K Verma; Prasenjit Das; Prabhash Mishra; Sanjeev Sinha; Anant Mohan; V Sreenivas; Siddhartha Datta Gupta; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2013-09-01

Review 5.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

6.  Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Authors:  Elio Tonutti; Daniela Visentini; Alessia Picierno; Nicola Bizzaro; Danilo Villalta; Renato Tozzoli; Graziano Kodermaz; Antonio Carroccio; Giuseppe Iacono; Saverio Teresi; Stella Maria La Chiusa; Ignazio Brusca
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 7.  Emerging technologies in upper gastrointestinal endoscopy and celiac disease.

Authors:  Giovanni Cammarota; Paolo Fedeli; Antonio Gasbarrini
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-11

8.  Increasing Incidence and Altered Presentation in a Population-based Study of Pediatric Celiac Disease in North America.

Authors:  Eyad Almallouhi; Katherine S King; Bhavisha Patel; Chung Wi; Young J Juhn; Joseph A Murray; Imad Absah
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

9.  Parasites in patients with malabsorption syndrome: a clinical study in children and adults.

Authors:  Bijayini Behera; B R Mirdha; Govind K Makharia; Shinjini Bhatnagar; Siddhartha Dattagupta; J C Samantaray
Journal:  Dig Dis Sci       Date:  2007-08-31       Impact factor: 3.199

Review 10.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.